Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 08:30 ET | Source: Microbot Medical Inc.

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
March 26, 2026 02:00 ET | Source: GAM Holding AG

GAM gibt Ergebnisse für das Gesamtjahr 2025 bekannt

26. März 2026 MEDIENMITTEILUNG Ad-hoc-Mitteilung gemäss Art. 53 KR: GAM gibt Ergebnisse für das Gesamtjahr 2025 bekannt GAM vollständig auf Wachstum fokussiert – mit gestärkter Plattform, neuen...
March 26, 2026 02:00 ET | Source: GAM Holding AG

GAM announces 2025 full year results

GAM Holding AG: FY2025 Annual Report
March 25, 2026 18:33 ET | Source: Liberty Gold Corp.

Liberty Gold Reports Year-End 2025 Financial and Operating Results

VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) ("Liberty Gold" or the “Company”), is pleased to announce its financial and operating...
March 25, 2026 08:23 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

Stock Investigations: ASP Isotopes (NASDAQ: ASPI); Integer Holdings (NYSE: ITGR); Molina Healthcare (NYSE: MOH); and Soleno Therapeutics (NASDAQ: SLNO)
March 25, 2026 06:00 ET | Source: Supercritical; Liferaft; Microsoft

Liferaft Announces a 10-Year, 1 Million Carbon Removal Units Offtake Agreement with Microsoft

WEST LIBERTY, Iowa, March 25, 2026 (GLOBE NEWSWIRE) -- Liferaft, a United States–based biochar company, has finalized an agreement to supply Microsoft with one million high-quality carbon removal...
March 24, 2026 16:01 ET | Source: Liberty Global Ltd.

Liberty Global Schedules Investor Call for First Quarter 2026 Results

DENVER, March 24, 2026 (GLOBE NEWSWIRE) -- Liberty Global Ltd. (“Liberty Global” or the “Company”) (NASDAQ: LBTYA, LBTYB and LBTYK) today announced plans to release its first quarter 2026 results on...
March 24, 2026 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

Microbot Medical® Strengthens LIBERTY®’s Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
March 24, 2026 02:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
March 24, 2026 02:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results...